AngioDynamics, Inc. (NASDAQ: ANGO) reported Q4 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $94.1 million versus the consensus estimate of $93.65 million.

For earnings history and earnings-related data on AngioDynamics, Inc. (ANGO) click here.